Understanding the role of the Tanzania Medicines and Medical Devices Authority

Advancements in pharmacovigilance in East Africa

Understanding pharmacovigilance in Namibia

Advances in pharmacovigilance in Nigeria

Understanding pharmacovigilance challenges in Lesotho & Swaziland

The evolution of pharmacovigilance: Lessons from thalidomide

Enhancing medicine safety monitoring in Zambia

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer

Primary IVIG supplementation reduces the risk of high-grade infections in patients receiving teclistamab therapy for MM

Analysis of dexamethasone-enhanced pre-medication in motixafortide-induced haematopoietic stem cell mobilisation for MM